Recent advances in chemoprevention of cancer.
暂无分享,去创建一个
[1] D. Bostwick,et al. Androgen deprivation as a strategy for prostate cancer chemoprevention. , 1997, Journal of the National Cancer Institute.
[2] M Buyse,et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Sporn,et al. Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid. , 1996, Journal of the National Cancer Institute.
[4] D. Williams,et al. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. , 1994, The Journal of clinical investigation.
[5] R. Lotan,et al. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. , 1997, Journal of the National Cancer Institute.
[6] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[7] M. Sporn,et al. Carcinogenesis and cancer: different perspectives on the same disease. , 1991, Cancer research.
[8] M. Anver,et al. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. , 1995, Cancer research.
[9] W. Clark,et al. The nature of cancer: morphogenesis and progressive (self)-disorganization in neoplastic development and progression. , 1995, Acta oncologica.
[10] M. Gottardis,et al. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand. , 1996, Cancer research.
[11] S. Lippman,et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] V. Jordan. Tamoxifen: the herald of a new era of preventive therapeutics. , 1997, Journal of the National Cancer Institute.
[13] A. Glasebrook,et al. Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and Raloxifene , 1996, Science.
[14] P. Vielh,et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.
[15] S. Allison,et al. UNDERNUTRITION AND FEMORAL FRACTURE , 1983, The Lancet.
[16] L J Peters,et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.
[17] R. Lotan,et al. Biomarkers as intermediate end points in chemoprevention trials. , 1990, Journal of the National Cancer Institute.
[18] J S Lee,et al. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. , 1995, The New England journal of medicine.
[19] W. Hong,et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. , 1986, The New England journal of medicine.
[20] D. Alberts,et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. , 1994, Journal of the National Cancer Institute.
[21] M. Boehm,et al. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. , 1995, Journal of medicinal chemistry.
[22] H. Moriwaki,et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. , 1996, Digestion.
[23] M. Sporn,et al. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. , 1991, Cancer research.
[24] S. Piantadosi,et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.
[25] M. Bertagnolli,et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. , 1996, Cancer research.
[26] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[28] K. Grandien,et al. Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .